Axura
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Axura, covering 2025-06-20 to 2025-06-20. Get the full timeline:
Most recent: EMA Authorised: Axura (memantine hydrochloride) — Merz Pharmaceuticals GmbH